{"prompt": "['Discontinuation of long-acting prohibited medications that require more than a 2-week', 'washout should be discussed on a case-by-case basis with the Medical Monitor for', 'approval of a longer screening phase to ensure washout of excluded medication with', 'longer half-life (e.g., fluoxetine) under the supervision of the investigator before', 'baseline.', 'Acetaminophen (Paracetamol) use is prohibited, but ibuprofen is allowed.', \"Use of all concomitant medications will be recorded in the patient's eCRF. As a\", 'minimum requirement, the drug name and dates of administration are to be recorded.', 'This will include all prescription drugs, herbal products, vitamins, minerals, and over-', 'the-counter medications. Any changes in concomitant medications will also be', \"recorded in the patient's eCRF.\", 'Any concomitant medication deemed necessary for the welfare of the patient during the', 'study may be given at the discretion of the investigator. However, it is the responsibility', 'of the investigator to ensure that details regarding the medication are recorded in full in', 'the eCRF.', 'Intra-Cellular Therapies, Inc. Confidential', '27 ITI-007-404 Protocol Amendment V 1.3 November 5, 2018']['7', 'STUDY SCHEDULE', 'Before participating in any study procedures, all potential study patients must sign an', 'informed consent form (ICF). Patients will have the opportunity to have any questions', 'answered before signing the ICF. The investigator must address all questions raised by', 'the patient. The investigator will also sign the ICF and a signed copy will be provided to', 'the patient.', 'The schedule of events for the study is presented in Appendix A. Detailed instructions', 'for the conduct of study assessments and procedures will be provided in the study', 'reference manual.', 'Intra-Cellular Therapies, Inc. Confidential', '28 ITI-007-404 Protocol Amendment V 1.3 November 5, 2018']['Intra-Cellular Therapies, Inc. Confidential', '29 ITI-007-404 Protocol Amendment V 1.3 November 5, 2018']\n\n###\n\n", "completion": "END"}